Ledger.Open graph →
SEC Form D · Amendment · filed March 25, 2022

Elastrin Therapeutics, Inc

Offering
$2.5M
Sold
$2.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SIMPSONVILLE, SC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Matthias Breugelmans · Simpsonville, SCExec · DirectorPatrick Burgermeister · Simpsonville, SCDirectorNaren Vyavahare · Simpsonville, SCExec · DirectorRobel Chappini · Gardens, Cape Town, T3Exec · DirectorGeorge Rzepecki · Gardens, Cape Town, T3Exec · DirectorKiaan Pillay · Gardens, Cape Town, T3DirectorJeff Feinstein · SEATTLE, WADirectorSrini A. Surendranath · Powell, OHExec · DirectorDaniel A. Charna · Powell, OHExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗